[HTML][HTML] Pretomanid resistance: an update on emergence, mechanisms and relevance for clinical practice

TVA Nguyen, QH Nguyen, TNT Nguyen… - International Journal of …, 2023 - Elsevier
Abstract Pretomanid (PA-824), a novel anti-tuberculosis nitroimidazoxazine, has been
approved for multidrug-resistant tuberculosis treatment for a few years. Pretomanid has …

Advancing the chemotherapy of tuberculous meningitis: a consensus view

S Wasserman, J Donovan, E Kestelyn… - The Lancet Infectious …, 2025 - thelancet.com
Tuberculous meningitis causes death or disability in approximately 50% of affected
individuals and kills approximately 78 200 adults every year. Antimicrobial treatment is …

Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs

X Chen, B Arun, OJ Nino-Meza, MO Sarhan… - Nature …, 2024 - nature.com
Tuberculosis (TB) remains a leading cause of death, but antibiotic treatments for tuberculous
meningitis, the deadliest form of TB, are based on those developed for pulmonary TB and …

Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis

E Ardiansyah, J Avila-Pacheco, S Dian, DN Vinh… - Elife, 2023 - elifesciences.org
Background: Cellular metabolism is critical for the host immune function against pathogens,
and metabolomic analysis may help understand the characteristic immunopathology of …

[PDF][PDF] Tuberculous Meningitis-New Approaches Needed

S Wasserman, TS Harrison - N Engl J Med, 2023 - openaccess.sgul.ac.uk
The clinical effects of infectious diseases are determined by a complex interplay between
pathogen and immune response, a dynamic ex emplified by tuberculous meningitis. Despite …

Linezolid does not improve bactericidal activity of rifampin-containing first-line regimens in animal models of TB meningitis

EW Tucker, CA Ruiz-Bedoya, F Mota, C Erice… - International journal of …, 2024 - Elsevier
Tuberculous meningitis (TB meningitis) is the most devastating form of tuberculosis (TB) and
there is a critical need to optimize treatment. Linezolid is approved for multidrug resistant TB …

Nano-imaging agents for brain diseases: Environmentally responsive imaging and therapy

F Liang, Q You, X Ma, H Wang, C Wang, Z He, Y Yang… - Nano Research, 2023 - Springer
Precise imaging is essential for the accurate diagnosis and surgical guidance of brain
diseases but it is challenging due to the difficulties in crossing the blood-brain barrier (BBB) …

New approaches for imaging bacteria

SK Jain - Seminars in nuclear medicine, 2023 - Elsevier
Bacterial infections are a major threat to human health. Rapid and accurate diagnosis of
bacterial infections is essential for early interventions and rational use of antibiotic …

The Promise of Molecular Imaging: Focus on Central Nervous System Infections

S Shah, ML Turner, X Chen, BM Ances… - The Journal of …, 2023 - academic.oup.com
Central nervous system (CNS) infections can lead to high mortality and severe morbidity.
Diagnosis, monitoring, and assessing response to therapy of CNS infections is particularly …

Predictions of Bedaquiline Central Nervous System Exposure in Patients with Tuberculosis Meningitis Using Physiologically based Pharmacokinetic Modeling

K Mehta, P Balazki, PH van der Graaf, T Guo… - Clinical …, 2024 - Springer
Abstract Background and Objective The use of bedaquiline as a treatment option for drug-
resistant tuberculosis meningitis (TBM) is of interest to address the increased prevalence of …